#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Asthma Dermatitis atopic Dementia Alzheimer's type Type 2 diabetes mellitus Breast cancer metastatic Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Brain abscess Ocular myasthenia Epstein-Barr virus infection Necrotising enterocolitis neonatal Synovial sarcoma metastatic Partial lipodystrophy Endometrial adenocarcinoma Phenylketonuria Hereditary angioedema Acute leukaemia Noonan syndrome Hepatobiliary cancer T-cell lymphoma Hereditary haemorrhagic telangiectasia Meningitis meningococcal More trials…

    Learn about Rare Diseases

    Rhabdomyosarcoma recurrent Acute respiratory distress syndrome – Diagnostics Urea cycle disorder – Trials in Disease Haemolytic uraemic syndrome – Life with Disease Gaucher’s disease type III – Life with Disease Immunodeficiency congenital – Basic Information Factor VIII deficiency – Basic Information Lymphangioma – Life with Disease Soft tissue sarcoma – Treatment Congenital hypotransferrinaemia – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Nusinersen Zetomipzomib Camphor Ucart20X22 Pitavastatin Calcium Benzathine Benzylpenicillin Rp-1664 Sulfate Ag-946 Phosphate Abacavir ULVIPRUBART Azd8205 Paclitaxel Albumin-Bound Verapamil Gliquidone Pegunigalsidase Alfa Dextromethadone Hydrochloride Auto4 Dazostinag Sodium Gluconate Liquid Paraffin More therapies…

    Learn about Your Condition

    Tuberculosis Colon cancer stage III Metabolic surgery Peritonitis Decreased appetite Richter's syndrome Congenital myopathy Precocious puberty Labour pain Apathy Hypomagnesaemia Neurotrophic keratopathy Pancreatic carcinoma Spinal osteoarthritis Small intestine leiomyosarcoma More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Diagnostics And Consultation Center Convex Ltd.

Diagnostics And Consultation Center Convex Ltd.

Ulitsa Sinanishko Ezero 11a, Sofia, 1680, Bulgaria

Want to learn more about this study or check if you can participate? Contact us.

  • Study on the Effects of SAR443820 and Gadobutrol in Patients with Multiple Sclerosis

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Multiple sclerosis
    Investigated Drugs:
    • Gadobutrol
    • Oditrasertib
    Belgium Bulgaria France Germany Italy Poland +1

  • Study on the Effects of Verekitug (UPB-101) for Adults with Severe Asthma

    Not recruiting

    2 1
    Investigated Drugs:
    • Human Igg1 Kappa Monoclonal Antibody Against Crlf2
    Bulgaria Czechia Germany Italy Poland Spain

  • Study on Anifrolumab for Adults with Active Lupus Nephritis

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Lupus nephritis
    Investigated Drugs:
    • Anifrolumab
    Belgium Bulgaria France Germany Hungary Italy +2

  • Study on the Effectiveness and Safety of CHF 5993 Compared to CHF 1535 for Patients with Chronic Obstructive Pulmonary Disease (COPD)

    Not recruiting

    3 1
    Investigated Diseases:
    • Chronic obstructive pulmonary disease
    Investigated Drugs:
    • Beclometasone Dipropionate Anhydrous
    • Formoterol Fumarate Dihydrate
    • Glycopyrronium Bromide
    Bulgaria Czechia Hungary Poland Romania

  • Study on the Effectiveness and Safety of Guselkumab for Patients with Moderate to Severe Ulcerative Colitis

    Not recruiting

    3 1
    Investigated Diseases:
    • Colitis ulcerative
    Investigated Drugs:
    • Guselkumab
    Belgium Bulgaria Czechia France Germany Hungary +3

  • Study on the Effectiveness and Safety of Remibrutinib Compared to Teriflunomide for Patients with Relapsing Multiple Sclerosis

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Relapsing multiple sclerosis
    Investigated Drugs:
    • Charcoal, Activated
    • Colestyramine
    • Magnesium Citrate
    Austria Belgium Bulgaria Croatia Denmark Ireland +7

  • Study of inclisiran to prevent heart attacks and strokes in people with atherosclerotic cardiovascular disease

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Arteriosclerosis
    Investigated Drugs:
    • Atorvastatin
    • Rosuvastatin
    • Inclisiran
    Austria Belgium Bulgaria Croatia Czechia Denmark +18

  • Study on the Effectiveness and Safety of Guselkumab for Patients with Moderate to Severe Ulcerative Colitis

    Not recruiting

    4 1
    Investigated Diseases:
    • Colitis ulcerative
    Investigated Drugs:
    • Guselkumab
    Belgium Bulgaria Czechia France Germany Hungary +7

  • Study on the Safety and Effects of STAR-0215 for Adults with Hereditary Angioedema

    Not recruiting

    1 1 1
    Investigated Diseases:
    • Hereditary angioedema
    • Hereditary angioedema with C1 esterase inhibitor deficiency
    Investigated Drugs:
    • Star-0215
    Bulgaria Czechia Germany Poland

  • Study on RPT193 for Adults with Moderate-to-Severe Asthma Partially Controlled by Inhaled Corticosteroids and Long-Acting Beta 2 Agonists

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Asthma
    Investigated Drugs:
    • 3-[(3R)-3-[1-[5-Chloro-4-[[(1R)-1-(2,4-Dichlorophenyl)Ethyl]Amino]-6-Methylpyrimidin-2-Yl]Azetidin-3-Yl]Piperidin-1-Yl]-1-Methylcyclobutane-1-Carboxylic Acid
    • Salbutamol Sulfate
    • Salmeterol
    Bulgaria Czechia Poland
Previous Page
1 … 6 7 8 9 10
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!